NasdaqCM - Delayed Quote USD

Lantern Pharma Inc. (LTRN)

Compare
4.9500
+0.1400
+(2.91%)
At close: 4:00:01 PM EST
4.8004
-0.15
(-3.02%)
After hours: 6:13:54 PM EST

Insider Purchases Last 6 Months

SharesTransactions
Purchases 161,874 3
Sales 847,778 5
Net Shares Purchased (Sold) -685,904 8
Total Insider Shares Held 1.59M --
% Net Shares Purchased (Sold) -30.20% --

Net Institutional Purchases Prior Quarter to Latest Quarter

Shares
Net Shares Purchased (Sold) --
% Change in Institutional Shares Held --

Insider Transactions Reported - Last Two Years

InsiderTransactionTypeValueDate
KEYSER DONALD JEFFREY PH.D Director Conversion of Exercise of derivative security at price 4.42 per share. Direct 16,937 Jul 24, 2024
KREIS LESLIE W JR Beneficial Owner of more than 10% of a Class of Security Sale at price 6.25 - 6.33 per share. Indirect 189,100 May 24, 2024
KREIS LESLIE W JR Beneficial Owner of more than 10% of a Class of Security Sale at price 4.40 - 4.87 per share. Indirect 676,294 Feb 29, 2024
FLETCHER AARON G.L. Beneficial Owner of more than 10% of a Class of Security Conversion of Exercise of derivative security at price 3.13 per share. Indirect 247,336 Jan 17, 2024
KREIS LESLIE W JR Beneficial Owner of more than 10% of a Class of Security Conversion of Exercise of derivative security at price 3.13 per share. Indirect 247,336 Jan 17, 2024
FLETCHER AARON G.L. Beneficial Owner of more than 10% of a Class of Security Sale at price 4.20 per share. Indirect 247,334 Jan 17, 2024
KREIS LESLIE W JR Beneficial Owner of more than 10% of a Class of Security Sale at price 4.20 per share. Indirect 247,334 Jan 17, 2024
FLETCHER AARON G.L. Beneficial Owner of more than 10% of a Class of Security Sale at price 3.44 per share. Indirect 499,997 Nov 29, 2023
KREIS LESLIE W JR Beneficial Owner of more than 10% of a Class of Security Sale at price 3.44 per share. Indirect 499,997 Nov 29, 2023

Related Tickers